ATE190836T1 - Arzneimittelzusammensetzung mit kontrollierter wirkstoffabgabe - Google Patents

Arzneimittelzusammensetzung mit kontrollierter wirkstoffabgabe

Info

Publication number
ATE190836T1
ATE190836T1 AT94120709T AT94120709T ATE190836T1 AT E190836 T1 ATE190836 T1 AT E190836T1 AT 94120709 T AT94120709 T AT 94120709T AT 94120709 T AT94120709 T AT 94120709T AT E190836 T1 ATE190836 T1 AT E190836T1
Authority
AT
Austria
Prior art keywords
inner layer
drug formulation
water
active ingredients
controlled release
Prior art date
Application number
AT94120709T
Other languages
English (en)
Inventor
Keiji Fujioka
Takeshi Hirasawa
Masako Kajihara
Akihiro Sano
Shuichi Sugawara
Yosuke Urabe
Original Assignee
Dow Corning Asia Ltd
Sumitomo Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Corning Asia Ltd, Sumitomo Pharma filed Critical Dow Corning Asia Ltd
Application granted granted Critical
Publication of ATE190836T1 publication Critical patent/ATE190836T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
AT94120709T 1993-12-27 1994-12-27 Arzneimittelzusammensetzung mit kontrollierter wirkstoffabgabe ATE190836T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33146793A JP3720386B2 (ja) 1993-12-27 1993-12-27 薬物放出制御製剤

Publications (1)

Publication Number Publication Date
ATE190836T1 true ATE190836T1 (de) 2000-04-15

Family

ID=18243976

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94120709T ATE190836T1 (de) 1993-12-27 1994-12-27 Arzneimittelzusammensetzung mit kontrollierter wirkstoffabgabe

Country Status (15)

Country Link
US (1) US5851547A (de)
EP (1) EP0659406B1 (de)
JP (1) JP3720386B2 (de)
KR (1) KR100349960B1 (de)
CN (1) CN1107497C (de)
AT (1) ATE190836T1 (de)
AU (1) AU686713B2 (de)
CA (1) CA2139058C (de)
DE (1) DE69423582T2 (de)
DK (1) DK0659406T3 (de)
ES (1) ES2146633T3 (de)
GR (1) GR3033248T3 (de)
NZ (1) NZ277548A (de)
PT (1) PT659406E (de)
WO (1) WO1995017881A1 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6056734A (en) * 1997-02-07 2000-05-02 Sarcos Lc Method for automatic dosing of drugs
TW586934B (en) * 1997-05-19 2004-05-11 Sumitomo Pharma Immunopotentiating composition
ATE316779T1 (de) 1997-06-04 2006-02-15 Debio Rech Pharma Sa Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung
TW586944B (en) 1998-05-29 2004-05-11 Sumitomo Pharma Controlled release agent having a multi-layer structure
US20020087184A1 (en) * 1998-06-18 2002-07-04 Eder Joseph C. Water-soluble coating for bioactive devices
MXPA01002609A (es) * 1998-09-10 2002-04-08 Sumitomo Pharma Preparacion de farmaco de liberacion sostenida a largo plazo.
US6217895B1 (en) * 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
AU3957400A (en) * 1999-04-16 2000-11-02 Novo Nordisk A/S Dry, mouldable drug formulation
BR0014141A (pt) * 1999-08-25 2002-07-16 Univ Georgetown Sistema de aplicação para terapia que compreende bulbos ocos, preferivelmente metálicos, e a sua utilização
TW524696B (en) * 1999-11-10 2003-03-21 Sumitomo Pharma Sustained-release drug formulations
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
JP2002003406A (ja) * 2000-06-21 2002-01-09 Sankyo Co Ltd 脳血管攣縮予防製剤
DE60127139T2 (de) * 2000-07-14 2007-12-13 Novo Nordisk A/S Verfahren zum formen einer pharmazeutischen zusammensetzung in einem verpackungsmaterial
WO2003000156A1 (en) 2001-06-22 2003-01-03 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR602401A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
AUPR951501A0 (en) * 2001-12-14 2002-01-24 Smart Drug Systems Inc Modified sustained release pharmaceutical system
US8454997B2 (en) 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
NZ534317A (en) * 2002-01-24 2006-06-30 Smart Drug Systems Inc Sustained release pharmaceutical composition carried in or on silicone support material
JP4026745B2 (ja) * 2002-03-26 2007-12-26 財団法人大阪産業振興機構 医療用システムおよびその製造方法
US8871241B2 (en) 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
JP4668611B2 (ja) 2002-05-31 2011-04-13 タイタン ファーマシューティカルズ インコーポレイテッド ブプレノルフィンの持続放出のための埋め込み型ポリマー製装置
ES2359977T3 (es) 2003-03-31 2011-05-30 Titan Pharmaceuticals, Inc. Dispositivo polimérico implantable para liberación sostenida de agonista de dopamina.
TWI336627B (en) * 2003-05-23 2011-02-01 Organon Nv Drug delivery system,and use and manufacturing method thereof
AU2004247057A1 (en) * 2003-05-30 2004-12-23 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of nalmefene
WO2005000278A1 (en) * 2003-06-26 2005-01-06 Mediolanum Pharmaceuticals Ltd. Subcutaneous implants having limited initial release of the active principle and subsequent linearly varying extended release thereof
CA2575988C (en) 2004-08-04 2014-02-18 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
EP1968383B1 (de) 2005-12-12 2011-05-11 Women and Infants Hospital of Rhode Island Derivate von vitamin d und ihre verwendung in der therapie
US20080081064A1 (en) * 2006-09-28 2008-04-03 Surmodics, Inc. Implantable Medical Device with Apertures for Delivery of Bioactive Agents
WO2008070557A2 (en) * 2006-12-01 2008-06-12 Women & Infants Hospital Organometallic complexes as therapeutic agents
US20080153906A1 (en) * 2006-12-13 2008-06-26 Celly Chander S Water-Soluble Phenicol Prodrugs in a Lipophilic Vehicle System
US8193180B2 (en) 2007-01-24 2012-06-05 Women & Infants Hospital N-amino tetrahydrothiazine derivatives, method of manufacture and use
US8741329B2 (en) * 2007-09-21 2014-06-03 Merck Sharp & Dohme B.V. Drug delivery system
JP5502751B2 (ja) 2007-12-20 2014-05-28 エボニック コーポレイション 低残留溶媒濃度を有する微粒子を調製するためのプロセス
US9186336B2 (en) 2009-02-06 2015-11-17 The General Hospital Corporation Methods of treating vascular lesions
EP2246063A1 (de) 2009-04-29 2010-11-03 Ipsen Pharma S.A.S. GnRH Analoge enthaltende Retardformulierungen
CN102596097B (zh) 2009-06-03 2015-05-20 弗赛特实验室有限责任公司 一种眼插入件
US9040062B2 (en) 2010-08-06 2015-05-26 Sumitomo Dainippon Pharma Co., Ltd. Preparation for treatment of spinal cord injury
EP2601974A4 (de) 2010-08-06 2015-06-24 Sumitomo Dainippon Pharma Co Ltd Pharmazeutisches präparat zur steuerung der freisetzung eines wasserlöslichen wirkstoffs
WO2013040426A2 (en) 2011-09-14 2013-03-21 Forsight Labs, Llc Ocular insert apparatus and methods
DK2911623T3 (da) 2012-10-26 2019-10-28 Forsight Vision5 Inc Oftalmisk system til langvarig frigivelse af lægemiddel til øjet
ES2821528T3 (es) 2012-11-14 2021-04-26 Grace W R & Co Composiciones que contienen un material biológicamente activo y un óxido inorgánico no ordenado
US10596103B2 (en) 2013-12-11 2020-03-24 Merek Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
JP6359390B2 (ja) * 2014-09-05 2018-07-18 テルモ株式会社 インプラントデバイスおよびインプラントデバイス植え込み具
EP3283004A4 (de) 2015-04-13 2018-12-05 Forsight Vision5, Inc. Augeneinsatzzusammensetzung aus einem semikristallinen oder kristallinen pharmazeutischen wirkstoff
EP3522825B1 (de) * 2016-10-05 2023-06-07 Titan Pharmaceuticals, Inc. Implantierbare vorrichtungen zur arzneimittelabgabe mit reduzierter burst-freisetzung
JP2021529747A (ja) * 2018-06-25 2021-11-04 タイタン ファーマシューティカルズ インコーポレイテッド 親油性又は両親媒性医薬物質の放出のためのインプラント
KR102442807B1 (ko) * 2021-01-29 2022-09-15 주식회사 티온랩테라퓨틱스 초기 방출 제어된 데포 조성물 및 이의 제조방법

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3710795A (en) * 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US4351337A (en) * 1973-05-17 1982-09-28 Arthur D. Little, Inc. Biodegradable, implantable drug delivery device, and process for preparing and using the same
FR2240817B1 (de) * 1973-08-16 1981-04-17 Roland Offsetmaschf
JPS5513381Y2 (de) * 1974-02-21 1980-03-26
US3926188A (en) * 1974-11-14 1975-12-16 Alza Corp Laminated drug dispenser
JPS58781B2 (ja) * 1978-07-17 1983-01-07 風早 清志 畳表の自動裁断装置
US4191741A (en) * 1978-09-22 1980-03-04 Eli Lilly And Company Removable drug implant
DE3022800A1 (de) * 1980-06-19 1982-01-07 Bayer Ag, 5090 Leverkusen Verfahren zur temperaturregelung exothermer reaktionen durch ueberhitzung von wasserdampf
JPS62174031A (ja) * 1985-10-11 1987-07-30 Sumitomo Pharmaceut Co Ltd 高分子量薬物含有徐放性製剤
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
IT1188212B (it) * 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
EP0250374B1 (de) * 1986-06-17 1991-05-02 RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.a. Therapeutisches System mit geregelter Wirkstoffabgabe
US5322691A (en) * 1986-10-02 1994-06-21 Sohrab Darougar Ocular insert with anchoring protrusions
US4891223A (en) * 1987-09-03 1990-01-02 Air Products And Chemicals, Inc. Controlled release delivery coating formulation for bioactive substances
DK606288D0 (da) * 1988-03-24 1988-10-31 Bukh Meditec Praeparat
EP0406315B1 (de) * 1988-03-24 1992-11-11 Bukh Meditec A/S Geregelte verabreichungszusammensetzung
JPH02142738A (ja) * 1988-11-24 1990-05-31 Nippon Zeon Co Ltd 徐放性医薬製剤およびその製法
JP3118009B2 (ja) * 1991-04-16 2000-12-18 住友製薬株式会社 多層構造を有するコラーゲンおよび／またはゼラチン製剤の製造方法
JPH06321803A (ja) * 1993-05-17 1994-11-22 Kirin Brewery Co Ltd 水溶性ペプチドホルモンの徐放性製剤

Also Published As

Publication number Publication date
WO1995017881A1 (en) 1995-07-06
JPH07187994A (ja) 1995-07-25
PT659406E (pt) 2000-06-30
JP3720386B2 (ja) 2005-11-24
NZ277548A (en) 1997-05-26
US5851547A (en) 1998-12-22
AU1280995A (en) 1995-07-17
CA2139058A1 (en) 1995-06-28
AU686713B2 (en) 1998-02-12
CA2139058C (en) 2004-11-16
ES2146633T3 (es) 2000-08-16
DK0659406T3 (da) 2000-07-03
CN1107497C (zh) 2003-05-07
CN1142763A (zh) 1997-02-12
EP0659406B1 (de) 2000-03-22
DE69423582T2 (de) 2000-09-07
EP0659406A2 (de) 1995-06-28
KR100349960B1 (ko) 2003-03-06
GR3033248T3 (en) 2000-09-29
DE69423582D1 (de) 2000-04-27
EP0659406A3 (de) 1995-11-15

Similar Documents

Publication Publication Date Title
ATE190836T1 (de) Arzneimittelzusammensetzung mit kontrollierter wirkstoffabgabe
GB2341550A (en) Gastroretentive controlled release microspheres for improved drug delivery
BR9607752A (pt) Formulação farmacêutica de microcápsula de liberação controlada, processo para sua preparação, e, processo de uso das microcápsulas
DE69425453D1 (de) Wirkstoffabgabevorrichtung mit gesteuerter Freigabe
GEP20022833B (en) New Controlled Release Bead, Method of Producing the Same and Multiple Unit Formulation Comprising It
MX9700850A (es) Formulaciones y metodos para proporcionar anestesia local prolongada.
UA29563C2 (uk) Мікрокапсула для тривалого вивільнення фізіологічно активного пептиду
DK0841903T3 (da) Orale farmaceutiske præparater indeholdende antimikrobielt virksomme aktivstoffer og sustained release pantoprazol
ATE290836T1 (de) Intravaginal-ringe mit einsetzbarem medikamentenenthaltenden kern
DK0610178T3 (da) Terapeutisk præparat og fremgangsmåde til dets fremstilling
ATE381926T2 (de) Vitaminzusammenstellung mit verzögerter freigabe
KR900007397A (ko) 서방성 제제
DK1112739T3 (da) Langtidsafgivende depot-præparat
ES491307A0 (es) Un procedimiento para la preparacion de una composicion de liberacion controlada de un compuesto biologicamente activo para su administracion a un animal
GR3006966T3 (en) Pharmaceutical composition comprising a medicament and a water-swellable polymer
DK0416722T3 (da) Farmaceutiske præparater med differentieret medikamentfrigivelseshastighed
IT1317871B1 (it) Sistemi terapeutici per forme farmaceutiche orali di principi attiviaventi sfavorevoli caratteristiche organolettiche.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EEIH Change in the person of patent owner